Huaren Pharmaceutical Company Description

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China.

It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections.

The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and sugar metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks.

In addition, it offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products.

The company was founded in 1998 and is based in Qingdao, China.

Huaren Pharmaceutical Co., Ltd.

Country	China
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,491
CEO	Jian Lin

Contact Details

Address: High-tech Industrial Park Qingdao, 266101 China
Phone	86 532 8870 1000
Website	qdhuaren.com

Stock Details

Ticker Symbol	300110
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000SW1
SIC Code	2834

Key Executives

Name	Position
Jian Lin	President
Liping Han	Vice President and Chief Financial Officer
Xiangyuan Meng	Vice President, Board Secretary and Accounting Supervisor
Junhong Wang	Vice President
Li Ming	Vice President
Xinguang Feng	Vice President